Drugs / HP011-101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01433159 | Sep 2011 → Jan 2013 | decubitus ulcer, spinal cord injury | Healthpoint | Terminated | No outcome recorded Stop: Business |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01273428 Comparator | ? → Jun 2011 | decubitus ulcer | Healthpoint | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HP011-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01273428 ↗ |
| Known as | Xenaderm | “HP011-101 (Xenaderm Ointment)” NCT01433159 ↗ |
| Route | Topical | “The test article will be applied at approximately the thickness of a dime twice daily” NCT01433159 ↗ |